Biotechnology News 
This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 23.
SciClone Pharmaceuticals, Inc.: SciClone Increases Stock Repurchase Program
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FOSTER CITY, CA (MARKET WIRE) SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that its board of directors has approved an increase of approximately $10.5 million to the Company's stock repurchase program. The increase brings the total authorized since the program's inception in October 2011 to approximately $30.5 million. The total amount repurchased to date is approximately $10.5 million.
Source: Market Wire - Pharmaceuticals and Biotech - May 29, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech SCLN Source Type: news
Zealand Pharma to Present at Upcoming Global Healthcare Investor Conferences in the USEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
COPENHAGEN, Denmark, May 29, 2012 (GLOBE NEWSWIRE) -- Zealand Pharma A/S (Copenhagen:ZEAL), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, today announces that the company will present at the following upcoming healthcare investor conferences:
Source: Medical News (via PRIMEZONE) - May 29, 2012 Category: Pharmaceuticals Source Type: news
Abandoned Drug for Sleep Disorder Blocks Neuronal Cancer TumorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Investigators at the Fred Hutchinson Cancer Research Center, in collaboration with Scientists at Merck & Co., just published a study where they identified a set of genes required for cancers whose growth is driven by the "Myc" oncogene. In the search for new cancer treatments, there is a lot of focus on finding possible gene targets for drugs in disrupted signaling pathways that cause uncontrolled cell growth. The Myc gene is a central regulator for many, if not most, of these growth signal pathways, but it has been difficult to find drugs that can be used directly against this gene....Read Full Post
Source: About.com Biotech Biomedical - May 29, 2012 Category: Biotechnology Source Type: news
£425,000 Queen's study could lead to new treatments for reversing symptoms of multiple sclerosisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Queen's University Belfast) A novel study at Queen's University Belfast which could eventually lead to new treatments for multiple sclerosis has been awarded £425K by the Biotechnology and Biological Sciences Research Council.
Source: EurekAlert! - Biology - May 29, 2012 Category: Biology Source Type: news
Andromeda Announces FDA Orphan Drug Designation for DiaPep277 for the Treatment of Type 1 Diabetes With Residual Beta Cell FunctionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YAVNE, Israel, May 28, 2012 (GLOBE NEWSWIRE) -- Andromeda Biotech Ltd. today announces that the US Food and Drug Administration (FDA) granted Orphan Drug designation for DiaPep277(r) for the treatment of type 1 diabetes (T1D) patients with residual beta cell function.
Source: Medical News (via PRIMEZONE) - May 28, 2012 Category: Pharmaceuticals Source Type: news
Ranbaxy receives USFDA approval for anti acne drug AbsoricaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ranbaxy laboratories has received an approval for an anti acne drug Absorica developed by US firm Cipher, the company said in a release to the exchanges.
Source: The Economic Times Healthcare and Biotech News - May 28, 2012 Category: Pharmaceuticals Source Type: news
Fighting Flu Virus Using Powerful New ApproachEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An international research team has manufactured a new protein that can combat deadly flu epidemics. The paper, featured on the cover of the current issue of Nature Biotechnology, demonstrates ways to use manufactured genes as antivirals, which disable key functions of the flu virus, said Tim Whitehead, assistant professor of chemical engineering and materials science at Michigan State University...
Source: Health News from Medical News Today - May 28, 2012 Category: Consumer Health News Tags: Flu / Cold / SARS Source Type: news
Anti-GM protesters kept from tearing up wheat crop by policeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Police use trespass order and mounted officers to halt hundreds of activists at entrance to land owned by Rothamsted ResearchPolice kept hundreds of protesters at bay as they attempted to destroy a field where genetically modified wheat is being tested in Hertfordshire.Mounted officers helped bring activists to a halt in front of the entrance to land owned by the Rothamsted research institute, which is testing GM wheat which has been enhanced to fight aphid infestation.The event on Sunday, which attracted hundreds of protesters including farmers, politicians and activists from the UK and abroad, had prompted the local coun...
Source: Guardian Unlimited Science - May 27, 2012 Category: Science Authors: Shiv Malik Tags: GM Farming Science Environment Police UK news Protest World news Activism The Guardian Source Type: news
Powerful new approach to attack flu virusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Michigan State University) An international research team has manufactured a new protein that can combat deadly flu epidemics. The paper, featured on the cover of the current issue of Nature Biotechnology, demonstrates ways to use manufactured genes as antivirals, which disable key functions of the flu virus, said Tim Whitehead, assistant professor of chemical engineering and materials science at Michigan State University.
Source: EurekAlert! - Biology - May 27, 2012 Category: Biology Source Type: news
Bristol researchers to gain from £250 million investment in UK biosciencesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers within the School of Biological Sciences are set to gain from the Biotechnology and Biological Sciences Research Council’s (BBSRC’s) recent announcement that it is to invest £250 million in UK bioscience.
Source: University of Bristol news - May 25, 2012 Category: Universities & Medical Training Authors: news_text Tags: Grants and awards Source Type: news
When Access To Drug Reps Is Restricted, Physicians May Be Slower To Drop 'Black Box' Drugs, Adopt New TherapiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
After years of reducing their contact with pharmaceutical sales representatives, physicians now risk an unintended consequence: Doctors who rarely meet with pharmaceutical sales representatives - or who do not meet with them - are much slower to drop medicines with the Food and Drug Administration's "black box" warnings and to adopt first-in-class therapies...
Source: Health News from Medical News Today - May 25, 2012 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news
New Discovery Brings Routine DNA Sequencing of Every Patient CloserEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As I mentioned in the recent overview on next-generation DNA sequencing, companies such as Oxford Nanopore Technologies, Nabsys, and ZS Genetics are developing the next wave of sequencing technologies using electronic sensing to read very long strands of single DNA molecules. The goal, of course, is to provide a system which cheap enough but fast enough to use routinely for whole genome sequencing of individual patients. A recent advance by Dr. Stuart Lindsay brings this vision much closer to reality as he may have solved one of the big problems plaguing Nanopore DNA sequencing....Read Full Post
Source: About.com Biotech Biomedical - May 25, 2012 Category: Biotechnology Source Type: news
Alarmists attack biotech in California — where else!Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Since their implementation in large-scale food production, genetically modified organisms (GMOs) — which have helped feed many of the world’s starving populations — have gotten much flak from environmental groups and the organic industry.
Source: Health Facts and Fears - May 25, 2012 Category: Consumer Health Advice Tags: Blogs Source Type: news
Royalty Pharma: Royalty Pharma Raises $600 Million of DebtEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NEW YORK, NY (MARKET WIRE) Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, announced that it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust ("RPIFT"), bringing total debt outstanding at RPIFT to approximately $3.4 billion. Proceeds will be used to fund future acquisitions.
Source: Market Wire - Pharmaceuticals and Biotech - May 24, 2012 Category: Pharmaceuticals Tags: Financial Services Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
Rx Response: Rx Response Beefs Up Technology for 2012 Hurricane SeasonEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON, DC (MARKET WIRE) The 2012 Atlantic hurricane season is set to officially begin and Rx Response has launched two technology enhancements to make the program an even more powerful resource in helping to ensure the continued flow of medicine to patients following a major hurricane or other disaster.
Source: Market Wire - Pharmaceuticals and Biotech - May 24, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
Dollars and Scents: The Chemistry of a Delicious TomatoEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The typical supermarket tomato: ripe red, firm to the touch, free of blemishes--and of flavor. Since at least the 1970s, U.S. consumers have lamented the beautiful but bland fruits that farmers breed not for taste, but rather for high yield and durability during shipping. Recently, organic farmers and foodies have championed the superior flavors of heirloom tomatoes --older varieties that come in an assortment of shapes, sizes and colors. In a new study, researchers took a close look at the chemical composition of both standard tomatoes and hundreds of different heirloom varieties, which they also fed to 170 volunteers in ...
Source: Scientific American Topic - Biotechnology - May 24, 2012 Category: Biotechnology Tags: More Science,Chemistry,History of Science,Society & Policy,Biotechnology,More Science,Biotechnology,Biology,Everyday Science Source Type: news
Novel Zeaxanthin-Producing Bacteria Isolated from a Radioactive Hot Spring WaterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Zeaxanthin is a powerful antioxidant that is widely found in vegetables and fruits. Epidemiological evidences suggest that increasing the consumption of zeaxanthin in the diet is associated with a lower risk of age-related macular degeneration, helps prevent glaucoma and cataracts, and supports normal eye health. Zeaxanthin is a promising nutraceutical with many applications in the feed, food, and pharmaceutical industries. Currently, the commercial production of zeaxanthin is still dependant on synthetic routes with limitation for the biological one. Nevertheless, the biotechnological production of zeaxanthin is emerging ...
Source: Springer protocols feed by Microbiology - May 24, 2012 Category: Microbiology Source Type: news
A Novel Radio-Tolerant Astaxanthin-Producing Bacterium Reveals a New Astaxanthin Derivative: Astaxanthin DirhamnosideEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Astaxanthin is a red ketocarotenoid that exhibits extraordinary health-promoting activities such as antioxidant, anti-inflammatory, antitumor, and immune booster. The recent discovery of the beneficial roles of astaxanthin against many degenerative diseases such as cancers, heart diseases, and exercise-induced fatigue has raised its market demand as a nutraceutical and medicinal ingredient in aquaculture, food, and pharmaceutical industries. To satisfy the growing demand for this high-value nutraceuticals ingredient and consumer interest in natural products, many research efforts are being made to discover novel microbial ...
Source: Springer protocols feed by Microbiology - May 24, 2012 Category: Microbiology Source Type: news
Isolation, Characterization, and Diversity of Novel Radiotolerant Carotenoid-Producing BacteriaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Carotenoids are natural pigments that exhibit many biological functions, such as antioxidants (i.e., promote oxidative stress resistance), membrane stabilizers, and precursors for vitamin A. The link between these biological activities and many health benefits (e.g., anticarcinogenic activity, prevention of chronic diseases, etc.) has raised the interest of several industrial sectors, especially in the cosmetics and pharmaceutical industries. The use of microorganisms in biotechnology to produce carotenoids is favorable by consumer and can help meet the growing demand for these bioactive compounds in the food, feed, and ph...
Source: Springer protocols feed by Microbiology - May 24, 2012 Category: Microbiology Source Type: news
Anther Culture of Chili Pepper (Capsicum spp.)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Chili pepper (Capsicum spp.) is a very important horticultural crop around the world and is especially important for Mexicans because of its impact in the culture and the cuisine. Biotechnological tools such as tissue culture techniques and specifically anther culture may be applied successfully for plant breeding and genetic improvement in order to generate isogenic lines (100% homozygous) in a shorter time in comparison with the classic breeding methods. In this chapter, a protocol for efficient recovery of chili pepper haploid plants from in vitro cultured anthers is described.
Source: Springer protocols feed by Plant Sciences - May 24, 2012 Category: Biology Source Type: news
Biolistic- and Agrobacterium-Mediated Transformation Protocols for WheatEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
After rice, wheat is considered to be the most important world food crop, and the demand for high-quality wheat flour is increasing. Although there are no GM varieties currently grown, wheat is an important target for biotechnology, and we anticipate that GM wheat will be commercially available in 10–15 years. In this chapter, we summarize the main features and challenges of wheat transformation and then describe detailed protocols for the production of transgenic wheat plants both by biolistic and Agrobacterium-mediated DNA-delivery. Although these methods are used mainly for bread wheat (Triticum aestivum L.), they...
Source: Springer protocols feed by Plant Sciences - May 24, 2012 Category: Biology Source Type: news
Appendix B: Plant Biotechnology and Tissue Culture Resources in the InternetEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This appendix compiles a list of useful Internet sites for cell culture scientists. A total of more than 100 sites have been selected, based on the quality of the information offered in them, as well as on their users’ friendliness. We anticipate that some of these sites will be included among the reader’s favorites (if they are not already).
Source: Springer protocols feed by Plant Sciences - May 24, 2012 Category: Biology Source Type: news
History of Plant Tissue CultureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Plant tissue culture, or the aseptic culture of cells, tissues, organs, and their components under defined physical and chemical conditions in vitro, is an important tool in both basic and applied studies as well as in commercial application. It owes its origin to the ideas of the German scientist, Haberlandt, at the beginning of the twentieth century. The early studies led to root cultures, embryo cultures, and the first true callus/tissue cultures. The period between the 1940s and the 1960s was marked by the development of new techniques and the improvement of those that were already in use. It was the availability of th...
Source: Springer protocols feed by Plant Sciences - May 24, 2012 Category: Biology Source Type: news
Measurement of Cell ViabilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An overview of the methods for assessing cell viability is presented. Different protocols of the most commonly used assays are described in detail so that the readers may be able to determine which assay is suitable for their own projects in plant biotechnology.
Source: Springer protocols feed by Plant Sciences - May 24, 2012 Category: Biology Source Type: news
CEO Bob Bradway Takes the Helm at AmgenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
[Ventura County Star,
Calif.]
From Ventura County Star (CA) (May 24, 2012)
May 23--Kevin Sharer stepped down as CEO of Amgen Inc. on
Wednesday after more than a decade piloting the Thousand Oaks
biotechnology...
Source: Drugs.com - Pharma News - May 24, 2012 Category: Pharmaceuticals Source Type: news
Innovative public-private collaboration launches to tackle antibiotic researchEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline and AstraZeneca today welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics.
Source: GSK news - May 24, 2012 Category: Pharmaceuticals Source Type: news
Sun Pharma gets USFDA nod for nasal spray AstelinEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sun Pharmaceutical Industries has received approval from the US health regulator to sell its generic version of Astelin, used in treating nasal allergies.
Source: The Economic Times Healthcare and Biotech News - May 24, 2012 Category: Pharmaceuticals Source Type: news
Minister announces £250M strategic investment in UK bioscienceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Biotechnology and Biological Sciences Research Council) Minister for Universities and Science, David Willetts, will today announce substantial funding that will ensure the UK's bioscience research base remains globally competitive and at the forefront of meeting the grand challenges faced by society in the coming decades. The announcement will be made by the Minister during a visit to the Babraham Research Campus, near Cambridge, and highlighted again during a major speech at the University of East Anglia in Norwich.
Source: EurekAlert! - Medicine and Health - May 24, 2012 Category: Global & Universal Source Type: news
India’s Economic Growth Leaves Human Development in the DustEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ahead of the Universal Periodic Review (UPR) of India, a coalition of NGOs denounced the gap between the country’s growth rate and the rate of poverty, malnutrition and lack of health and sanitation.
They charged that even when laws and policies exist, their implementation is unsatisfactory and assessment of efforts is a difficult undertaking.
“According to official figures, the average growth rate between 2007 and 2011 was 8.2 percent but poverty declined only by 0.8 percent. While this is already disturbing, standards used to measure poverty are very suspect. They are based on a poverty level of 50 cents a day, w...
Source: IPS Inter Press Service - Health - May 23, 2012 Category: Global & Universal Authors: Isolda Agazzi Tags: Civil Society Crime & Justice Development & Aid Economy & Trade Education Food & Agriculture Gender Gender Violence Health Human Rights Indigenous Rights LGBTQ Population Poverty & MDGs Religion Trade & Investment United Na Source Type: news
Use of Statistics in Plant BiotechnologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Statistics and experimental design are important tools for the plant biotechnologist and should be used when planning and conducting experiments as well as during the analysis and interpretation of results. This chapter provides some basic concepts important to the statistical analysis of data obtained from plant tissue culture or biotechnology experiments, and illustrates the application of common statistical procedures to analyze binomial, count, and continuous data for experiments with different treatment factors as well as identifying trends of dosage treatment factors.
Source: Springer protocols feed by Plant Sciences - May 23, 2012 Category: Biology Source Type: news
Lupin recall contraceptive drug in USEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
“This product is being recalled due to an out of specification test result for an individual unspecified impurity, identified as Bisphenol-A, during the 3 month long term stability testing,” US FDA said.
Source: The Economic Times Healthcare and Biotech News - May 23, 2012 Category: Pharmaceuticals Source Type: news
U.S. Government Sets Out Alzheimer's PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
From Nature magazine [More]
Source: Scientific American Topic - Biotechnology - May 23, 2012 Category: Biotechnology Tags: Health,Health,Pharmaceuticals,More Science,Biotechnology,Biotechnology,Biology,Society & Policy Source Type: news
QLT Responds With an Open Letter to StockholdersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, British Columbia, May 23, 2012 (GLOBE NEWSWIRE) -- The Board of Directors of QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today issued an open letter to stockholders in response to a filing made by NB Public Equity Komplementar ApS ("Nordic Biotech") proposing a dissident slate of directors for election at the Company's annual general meeting of shareholders on May 24, 2012.
Source: Medical News (via PRIMEZONE) - May 23, 2012 Category: Pharmaceuticals Source Type: news
QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of StockholdersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, British Columbia, May 23, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced that it has been notified that NB Public Equity Komplementar ApS ("Nordic Biotech") has deposited with Computershare Investor Services Inc. ("Computershare"), the Company's proxy administrator, a legal proxy representing an aggregate of approximately 7.4 million common shares of QLT that are instructed to be voted at the Company's annual general meeting of shareholders on May 24, 2012 (the "Annual Meeting") in favour of a dissident slate of directors nominated by Nordic Biotech.
Source: Medical News (via PRIMEZONE) - May 23, 2012 Category: Pharmaceuticals Source Type: news
BIOTRONIK SE. Co. KG: BIOTRONIK Announces Positive Results for Pulsar Stent in 4EVER Clinical StudyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BUELACH, SWITZERLAND (MARKET WIRE) The six-month results from the prospective, multicenter, single-arm 4EVER study demonstrate efficacy and safety of BIOTRONIK's Pulsar Stent System in 120 superficial femoral artery (SFA) patients. Analysis of the 120 patients showed excellent device performance, very promising patency rates and convincing evidence of the benefits of lower limb intervention on a 4F platform. Although only the interim results were presented at the Leipzig Interventional Course (LINC 2012) in Leipzig, Germany, analysis of the full cohort has recently been made available.
Source: Market Wire - Pharmaceuticals and Biotech - May 23, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
MarketResearch.com: US Medical Device Recalls Trigger Appeals for Stricter RegulationsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ROCKVILLE, MD (MARKET WIRE) MarketResearch.com has announced the addition of the new report "Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall," to their collection of Medical Devices market reports. For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Regulatory-Intelligence-Medical-Device-Recalls-692706
Source: Market Wire - Pharmaceuticals and Biotech - May 23, 2012 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Professional Services Source Type: news
Aurobindo Pharma gets USFDA nod for generic anti-HIV drugEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Aurobindo Pharma today said it has received final approval from the US health regulator for its generic Nevirapine tablets and oral suspension.
Source: The Economic Times Healthcare and Biotech News - May 23, 2012 Category: Pharmaceuticals Source Type: news
VBL Therapeutics VB-201 drug reduces IBD severityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VBL Therapeutics, a clinical stage biotechnology company, has announced that its drug candidate, VB-201, was found effective in attenuating inflammatory bowel disease (IBD) in preclinical models.
Source: Drug Development Technology - May 22, 2012 Category: Pharmaceuticals Source Type: news
Collaboration boosts AAV vectors for gene therapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Avalanche Biotechnologies Inc. and Lonza have announced a manufacturing collaboration focused on
process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene
therapy.
Source: Modern Medicine - May 22, 2012 Category: Journals (General) Source Type: news
GM crops: protesters go back to the battlefieldsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A decade ago anti-GM protesters tore up fields and Britain roundly rejected so-called 'Frankenfood'. Now, as researchers trial new crops, activists are once more squaring up to the scientists. But have the arguments changed?During the summer of 2003, more than 600 public meetings were held across the country on the order of the government. One was even held in the fictional town of Ambridge, setting for Radio 4's rural soap The Archers, such was the desire to spark a "national debate".At each event, attendees were asked about their attitudes towards a technology that left very few people on the fence – genetically modifi...
Source: Guardian Unlimited Science - May 22, 2012 Category: Science Authors: Leo Hickman Tags: GM Science Farming Environment Agriculture Plants Genetics The Guardian Features Source Type: news
Government prepares Bill to regulate bio-tech usagesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The government is gearing up to regulate the research and use of organisms and products of modern bio-technology.
Source: The Economic Times Healthcare and Biotech News - May 22, 2012 Category: Pharmaceuticals Source Type: news
Biocon's corporate governance standards raise an alarm among analystsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The termination of the insulin deal with Pfizer and an aggressive accounting policy has shadowed the company's future earnings, the report says.
Source: The Economic Times Healthcare and Biotech News - May 22, 2012 Category: Pharmaceuticals Source Type: news
James L. Sorenson Molecular Biotechnology Building, UtahEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
University of Utah's new innovation centre, the James L. Sorenson Molecular Biotechnology Building, was officially dedicated in April 2012.
Source: Pharmaceutical Technology - May 21, 2012 Category: Pharmaceuticals Source Type: news
Ipsen, Active Biotech conclude half of planned recruitment in tasquinimod studyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Active Biotech and Ipsen have announced that 600 patients have been recruited in the global, pivotal, randomised, double-blind, placebo-controlled Phase 3 study of tasquinimod, used to treat patients with metastatic castrate-resistant prostate cancer…
Source: Drug Development Technology - May 21, 2012 Category: Pharmaceuticals Source Type: news
Prolor CEO: It Would Make Sense to Find A PartnerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
[Globes, Tel
Aviv, Israel]
From Globes (Tel Aviv) (May 20, 2012)
May 20--Prolor Biotech Inc. (AMEX: PBTH; TASE: PBTH) has enough
cash to conduct late-stage studies of its longer-lasting...
Source: Drugs.com - Pharma News - May 21, 2012 Category: Pharmaceuticals Source Type: news
Farmer charged with criminal damage at GM crop trial siteEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Hector Christie charged for allegedly vandalising crops and property at government-funded Rothamsted ResearchA man has been charged with criminal damage to property at a research station housing a field trial of genetically modified wheat, according to Hertfordshire police.Hector Christie, 50, from Tapeley Park Lodge, Instow, in north Devon, was bailed to appear before central magistrates court on 13 July after allegedly vandalising the trial and surrounding property at the government-funded crop institute, Rothamsted Research in Harpenden.Christie, an old Etonian organic farmer who has campaigned against globalisation, is...
Source: Guardian Unlimited Science - May 21, 2012 Category: Science Authors: Ian Sample Tags: GM Farming Science Globalisation Environment guardian.co.uk News Source Type: news
Tunisia deal with India opens developing country linksEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tunisia has launched a mission to work with developing countries by agreeing to cooperate with India in biotechnology and medicine.
Source: SciDev.Net - May 21, 2012 Category: Global & Universal Source Type: news
Fortis Healthcare in deal talks to take control of Wockhardt HospitalsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Fortis is extremely keen to expand its footprint in the hospital sector in India and the Wockhardt Hospitals network has 9 hospitals.
Source: The Economic Times Healthcare and Biotech News - May 21, 2012 Category: Pharmaceuticals Source Type: news
AAPS National Biotechnology Conference to highlight innovative vaccinesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(American Association of Pharmaceutical Scientists) Vaccination studies from Mercer University (Ga.) headline the groundbreaking research being unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).
Source: EurekAlert! - Cancer - May 21, 2012 Category: Cancer & Oncology Source Type: news
Biomarker predicts response to cancer treatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(VIB (the Flanders Institute for Biotechnology)) VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab. If validated, this discovery could be an important step towards personalized medicine and patient-tailored use of this important cancer drug.
Source: EurekAlert! - Cancer - May 21, 2012 Category: Cancer & Oncology Source Type: news
